1. Accueil >
  2. Tresiba® trial shows that people with type 2 diabetes who avoid severe hypoglycaemia have a reduced risk of death >
Nasdaq

Tresiba® trial shows that people with type 2 diabetes who avoid severe hypoglycaemia have a reduced risk of death

15-09-2017


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via GlobeNewswire

HUG#2134217